Elixir Medical Corp
@elixirmed
Innovation for Life. Elixir Medical is committed to transforming care for patients with heart and vascular disease through innovation.
ID: 3280087819
http://elixirmedical.com 14-07-2015 23:46:40
348 Tweet
1,1K Followers
4,4K Following
Coming off a great #EuroPCR 2024! We were thrilled to share data on our transformational technologies and connect with those leading the way in #cardiovascular medicine! Flavio Ribichini, MIЯVΛƬ #IC, Michal Hawranek, Valeria Paradies, Dr Roxana Mehran Dr. AlexandreAbizaid
“The study suggests “an edge” with Bioadaptor in terms of TLF over the drug-eluting stent.” - Robert Byrne. Read TCTMD’s article on the #BIOADAPTOR RCT: tctmd.com/news/solid-2-y… Michael O'Riordan MIЯVΛƬ #IC #cardiotwitter CE marked. Not approved in the U.S. PMN 1887 REV A
ICYMI: Watch Antonio Colombo, Stefan Verheye, M.D., & Davide Capodanno share perspectives on #BIOADAPTOR RCT 2-year outcomes at #EuroPCR 2024 here: bit.ly/3XVO7ji CE marked. Not for sale in the U.S. #CardioTwitter PMN 1939 REV A
📣 Have you heard? #DynamX is available in leading innovation centers around the world! Michal Hawranek shares why he offers the therapy to his patients. Watch the full video here: bit.ly/4dtS3gh CE marked. Not for sale in the U.S. #cardiotwitter PMN 1943 Rev A
At #ESC2024, we’ll unveil late-breaking, 12-month primary outcomes from the 2,400-patient INFINITY-SWEDEHEART RCT evaluating #DynamX compared to contemporary DES. Read more: bwnews.pr/3X19EWL David Erlinge Stefan James CE marked. Not for sale in the U.S. PMN 1894 REV A
Watch MIЯVΛƬ #IC as she offers her perspective on the BIOADAPTOR RCT two-year data and the impact the results could have on her practice and the future of PCI. #cardiotwitter #Bioadaptor CE marked. Not for sale in the U.S. PMN 1993 REV A